[Clinical studies of cefaclor for respiratory tract infections].

Cefaclor (CCL) was administered to 27 patients with acute pneumonia and the following results were obtained. CCL was given 500 mg t. i. d. for 6 to 23 days. The clinical effects of CCL were excellent in 2 cases, good in 14 cases, fair in 6 cases and poor in 5 cases, the efficacy rate was 59.3%. No adverse reaction was observed. We conclude that CCL is considerably useful in the treatment of acute pneumonia of outpatients.
AuthorsY Hiraga, K Kikuchi, A Yamamoto
JournalThe Japanese journal of antibiotics (Jpn J Antibiot) Vol. 37 Issue 4 Pg. 581-8 (Apr 1984) ISSN: 0368-2781 [Print] JAPAN
PMID6471379 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Cefaclor
  • Cephalexin
  • Acute Disease
  • Administration, Oral
  • Adult
  • Aged
  • Cefaclor (administration & dosage, adverse effects, therapeutic use)
  • Cephalexin (analogs & derivatives)
  • Drug Evaluation
  • Female
  • Humans
  • Male
  • Middle Aged
  • Pneumonia (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: